Molecular Partners AG ADR (MOLN)

Molecular Partners AG ADR (MOLN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $165M; returns 1 day +1.7%, 1 week +3.1%, 1 year +3.1%.

Molecular Partners AG (MOLN) is a clinical-stage biotech company based in Switzerland, specializing in the development of DARPin (Designed Ankyrin Repeat Proteins) therapeutics. These custom-built protein drugs offer multi-functionality and multi-target specificity for drug design, primarily focused on oncology.

Groups MOLN belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Cancer Therapeutics
• Clinical Stage
• Biopharmaceutical
• Precision Medicine
• Life Sciences
• Strategic Partnerships

MOLN financial model: income statement, cash flow and balance sheet